Currently, Vincerx Pharma Inc’s (VINC) stock is trading at $0.81, marking a fall of -9.77% from last night’s close. At this price, the stock is -91.37% below its 52-week high of $9.37 and 32.63% above its 52-week low of $0.61. Based on the past 30-day period, the stock price is -88.15% below the high and +8.05% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, VINC’s SMA-200 is $1.7274.
VINC’s price to book ratio for the most recent quarter was 1.54, resulting in an 1.35 price to cash per share for the period.
How does Vincerx Pharma Inc (VINC) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 2 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Vincerx Pharma Inc (VINC): Earnings History
If we examine Vincerx Pharma Inc’s recent earnings history, in the last quarter ended on 12/31/2023, it posted adjusted earnings per share of -$0.23, slashing the consensus of -$0.37. In other words, it beat the consensus by $0.14, resulting in a 37.80% surprise. In the 3 months period before the previous quarter which was closed on 12/31/2023, the stock recorded adjusted earnings per share of -$0.23 in contrast with the Outlook of -$0.37. That was a difference of $0.14 and a surprise of 37.80%.
Vincerx Pharma Inc (VINC): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -0.26 and -0.26 with an average Earnings Estimate of -0.26 which is in contrast with the last year earnings estimate of -0.68 and also replicates 61.76% growth rate year over year.
An overview of Vincerx Pharma Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Vincerx Pharma Inc (VINC) traded 1,701,245 shares per day, with a moving average of $2.4038 and price change of -4.2496. With the moving average of $4.0063 and a price change of -0.9596, about 1,394,914 shares changed hands on average over the past 50 days. Finally, VINC’s 100-day average volume is 1,032,807 shares, alongside a moving average of $2.5498 and a price change of +0.1104.
